CareLit · DOI-Nachweis · Aktuelle Rheumatologie
Mycophenolate mofetil: Experience in two adolescents with systemic lupus erythematosus and Wegener's granulomatosis and severe renal involvement
DOI 10.1055/s-2003-45058
Bibliografische Angaben
Nachweis in CareLit
Autor:innenCM Gebauer, G Bürk, R Schille, V Schuster
ZeitschriftAktuelle Rheumatologie
Ausgabe11/2003
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Therapy of autoimmune diseases in childhood may be difficult due to prolonged requirement of toxic immunosuppressive agents. To induce remission, intravenous cyclophosphamide (CYC) or methylprednisolone are common. Infections and gonadal toxicity are major risks of CYC. In recent years new therapeutic agents have been developed. Reports on the use of mycophenolate mofetil (MMF, Cellcept®) in children w…
Zitieren
Zitierempfehlung
CM Gebauer, G Bürk, R Schille, V Schuster (2003) Mycophenolate mofetil: Experience in two adolescents with systemic lupus erythematosus and Wegener's granulomatosis and severe renal involvement. Aktuelle Rheumatologie (11). https://doi.org/10.1055/s-2003-45058
Mit CareLit weiterarbeiten